💉

Understanding Plasma Protein Binding Effects

May 3, 2025

Plasma Protein Binding

Overview

  • Definition: Plasma protein binding refers to how drugs attach to proteins within blood plasma.
  • Impact on Drug Efficacy: The degree of binding affects a drug’s ability to diffuse through cell membranes. Less bound drugs traverse more efficiently.
  • Common Blood Proteins: Human serum albumin, lipoprotein, glycoprotein, and globulins.

Drug Binding and Distribution

  • Forms in Blood: Drugs exist in two forms: bound and unbound.
  • Chemical Equilibrium: Reversible binding creates equilibrium between bound and unbound states.
  • Active Fraction: Only the unbound fraction has pharmacologic effects and can be metabolized/excreted.
    • Example: Warfarin’s fraction bound is 97%; 3% is active.
  • Biological Half-Life: Binding can affect half-life by acting as a drug reservoir.
  • Binding Specificity:
    • Albumin primarily binds acidic/neutral drugs.
    • Alpha-1 acid glycoprotein binds basic drugs.
  • Medical Conditions: Can affect levels of albumin, alpha-1 acid glycoprotein, and lipoproteins.

Impact of Altered Protein Binding

  • Metabolism: Only unbound drugs undergo metabolism in the liver and tissues.
  • Volume of Distribution: Changes with levels of free drug due to tissue distribution.
  • Clearance: For rapidly metabolized drugs, clearance is hepatic blood flow dependent; for others, unbound fraction changes affect clearance.
  • Measurement: Plasma concentration levels measure both bound and unbound drug fractions.
  • Variables Affecting Unbound Fraction:
    • Drug concentration, plasma protein amount/quality, and competing drugs.
    • Decreased plasma protein leads to a higher unbound fraction (e.g., malnutrition, disease).

Drug Interactions

  • Effect of Concurrent Drug Use: Drugs can displace each other, affecting the fraction unbound.
    • Example: Drug A and Drug B both protein-bound; Drug B increases Drug A’s unbound fraction.
  • Displacement Impact: In closed systems, displacement can significantly alter drug effect.
    • Real-world systems see rapid redistribution/excretion, minimizing impact.
    • Example with Warfarin and phenylbutazone demonstrates liver metabolism interference, not just displacement.

Key Points

  • Pharmacokinetic Considerations: Understanding protein binding is crucial for drug dosing and efficacy.
  • Clinical Relevance: Incorrect assumptions about drug displacement can lead to dangerous clinical implications.

See Also

  • Blood proteins
  • Pharmacokinetics

References

  • Toutain, P. L.; Bousquet-Melou, A. (2002). "Free Drug Fraction vs. Free Drug Concentration: A Matter of Frequent Confusion". Journal of Veterinary Pharmacology and Therapeutics.

Further Reading

  • Shargel, Leon (2005). Applied Biopharmaceutics & Pharmacokinetics.